Loading…
Chinese maker of chromatography packing materials and silica microspheres used in biopharma purification.
Chinese maker of chromatography packing materials and silica microspheres used in biopharma purification.
Packing materials are consumables: once a drug maker writes one into the approved purification step for a biologic, it is bought again as columns wear out, so early qualification is the key sale. The silica microspheres that form the base of the packing are also sold on their own.
In one line: A China-based chromatography-media specialist.
Moat: narrow (process know-how, customer qualification). Purification media must be qualified into biologics manufacturing processes.
Headquarters: Suzhou, China · Employees: 1,213
Size Suzhou Nanomicro Technology (688690.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $2.31B, the 1108th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥38.10 on 6 Nov 2026.
Performance Over six months the shares gained 16.8%, against +0.8% for the median peer and -16.4% for the China market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue grew 26.4% over the last twelve months (peer median +12.3%); the operating margin is 24.8% (peer median 14.7%).
Valuation It trades at 57.1× forward earnings against a peer median of 20.2× (5th most expensive of 18).
Price implies For today's price to make sense, revenue must grow about 35% a year for seven years (Req g). Recent delivered growth is +35%, so the hurdle is +0 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 0.5 points above its cost of capital (11.9% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.14B | CN¥916M | CN¥777M | CN¥587M | CN¥699M |
| Revenue growth | — | +18% | +32% | -16% | — |
| Gross profit | CN¥837M | CN¥609M | CN¥505M | CN¥435M | CN¥533M |
| EBITDA | n/a | CN¥246M | CN¥185M | CN¥105M | CN¥259M |
| Net income | CN¥250M | CN¥136M | CN¥82.8M | CN¥68.6M | CN¥275M |
| Free cash flow | CN¥259M | CN¥82.7M | -CN¥6.36M | CN¥980,160 | -CN¥43.8M |
| Capital expenditure | CN¥97.2M | CN¥85.6M | CN¥139M | CN¥125M | CN¥156M |
| Total debt | CN¥22.2M | CN¥66.4M | CN¥134M | CN¥219M | CN¥172M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Suzhou Nanomicro Technology 688690.SS | $2.31B | +17% | +26% | 25% | 57.1× | 35.3% |
| Tosoh 4042.T | $4.69B | -4% | -1% | 11% | 11.4× | -1.5% |
| Repligen RGEN | $11.1B | +41% | +14% | 9% | 71.3× | 56.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688690.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -13.6% | -0.4% | 8th lowest of 21 |
| 6-month return | +16.8% | +0.8% | 5th highest of 21 |
| Distance from 52-week high | -24.2% | -27.4% | 10th highest of 21 |
| Revenue growth (TTM) | +26.4% | +12.3% | 6th highest of 19 |
| Operating margin | 24.8% | 14.7% | 3rd highest of 20 |
| Forward P/E | 57.1× | 20.2× | 5th most expensive of 18 |
| Growth the price implies (Req g, 7 yrs) | 35.3% | 2.0% | 3rd most demanding of 15 |
| Growth delivered (Del g) | +35.2% | +14.3% | 3rd highest of 14 |
| Hurdle (Req g minus delivered) | +0.1 pp | -9.2 pp | 4th most demanding of 14 |
| ROIC minus cost of capital | +0.5 pp | +0.8 pp | 9th lowest of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Suzhou Nanomicro Technology 688690.SS | China | $2.31B | +17% | +26% | 25% | 57.1× | 35.3% | +35.2% |
| Sigurd Microelectronics 6257.TW | Taiwan | $2.33B | -19% | +12% | 22% | 14.0× | n/a | n/a |
| TIC Solutions TIC | United States | $2.26B | +5% | +39% | -1% | n/a | 51.8% | n/a |
| Ardentec 3264.TWO | Taiwan | $2.36B | -30% | +32% | 30% | 12.3× | 5.2% | +7.7% |
| V2X VVX | United States | $2.39B | +9% | +13% | 4% | 11.3× | -1.4% | +26.3% |
| Biocytogen Pharmaceuticals (Beijing) 688796.SS | China | $2.22B | -19% | +40% | 24% | 92.6× | 32.3% | +41.1% |
| Shanghai GenTech 688596.SS | China | $2.42B | +56% | +4% | 2% | 76.5× | n/a | n/a |
| China Automotive Engineering Research Institute 601965.SS | China | $2.18B | -8% | +12% | 24% | 13.2× | -5.6% | +7.9% |
| S-1 012750.KS | South Korea | $2.45B | +14% | +1% | 7% | 21.8× | -1.2% | +5.4% |
| Firstsource Solutions FSL.NS | India | $2.16B | +25% | +20% | 12% | 22.0× | 20.3% | +13.5% |
| Sagility SAGILITY.NS | India | $2.15B | +2% | +28% | 18% | 16.4× | 10.3% | +19.5% |
| KWS SAAT SE & Co KGaA KWS.DE | Germany | $2.48B | -12% | -3% | 15% | 13.2× | -8.2% | +4.4% |
| Visional 4194.T | Japan | $2.51B | +32% | +24% | 25% | 20.2× | -2.4% | +28.2% |
| CECEP Environmental Protection 300140.SZ | China | $2.51B | -18% | -2% | 23% | n/a | -1.2% | +26.0% |
| Hui Lyu Ecological Technology Groups 001267.SZ | China | $2.61B | -59% | +90% | 10% | 71.6× | n/a | n/a |
| International Workplace IWG.L | United Kingdom | $2.63B | +12% | 0% | 4% | 22.5× | 33.6% | +3.3% |
| Huron Consulting HURN | United States | $2.63B | +39% | +12% | 12% | 16.5× | -4.0% | +14.3% |
| Pluxee PLX.PA | France | $2.72B | 0% | +1% | 28% | 8.9× | n/a | n/a |
| Anhui XDLK Microsystem 688582.SS | China | $1.95B | -36% | -38% | 21% | 37.3× | 55.7% | +37.0% |
| Heron Neutron Medical 7799.TW | Taiwan | $1.94B | +15% | n/a | -5,071% | 380.6× | n/a | n/a |
| Xi'an Taijin New Energy & Materials Sci-Tech 688813.SS | China | $1.93B | -13% | n/a | n/a | n/a | n/a | n/a |